• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Why Diverse Clinical Trial Participation Matters.

作者信息

Schwartz Aaron L, Alsan Marcella, Morris Alanna A, Halpern Scott D

机构信息

From the Department of Medical Ethics and Health Policy (A.L.S., S.D.H.) and the Behavioral Economics to Transform Trial Enrollment Representativeness (BETTER) Center (A.A.M., S.D.H.), Perelman School of Medicine, University of Pennsylvania, and the Center for Health Equity Research and Promotion, Department of Veterans Affairs (A.L.S.) - both in Philadelphia; the Harvard Kennedy School of Government and the National Bureau of Economic Research - both in Cambridge, MA (M.A.); and the Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta (A.A.M.).

出版信息

N Engl J Med. 2023 Apr 6;388(14):1252-1254. doi: 10.1056/NEJMp2215609. Epub 2023 Apr 1.

DOI:10.1056/NEJMp2215609
PMID:37017480
Abstract
摘要

相似文献

1
Why Diverse Clinical Trial Participation Matters.为何多样化的临床试验参与至关重要。
N Engl J Med. 2023 Apr 6;388(14):1252-1254. doi: 10.1056/NEJMp2215609. Epub 2023 Apr 1.
2
Research reporting and evidence of effectiveness: why "no difference" matters.研究报告与有效性证据：为何“无差异”至关重要。
Am J Crit Care. 2008 May;17(3):218-20.
3
Clinical Trial Outcomes: What Matters to Patients.临床试验结果：对患者重要的因素。
JACC Heart Fail. 2019 Mar;7(3):272-273. doi: 10.1016/j.jchf.2018.12.003.
4
Involving South Asian patients in clinical trials.让南亚患者参与临床试验。
Health Technol Assess. 2004 Oct;8(42):iii, 1-109. doi: 10.3310/hta8420.
5
Conceptualizing, operationalizing, and utilizing equity, diversity, and inclusion in clinical trials: a scoping review.在临床试验中对公平、多样性和包容性进行概念化、实施和利用：一项范围综述
J Clin Epidemiol. 2025 Mar;179:111649. doi: 10.1016/j.jclinepi.2024.111649. Epub 2024 Dec 20.
6
Diversity in Cancer Care: Current Challenges and Potential Solutions to Achieving Equity in Clinical Trial Participation.癌症护理中的多样性：实现临床试验参与公平性的当前挑战和潜在解决方案。
Cancer J. 2023;29(6):310-315. doi: 10.1097/PPO.0000000000000675.
7
Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor.临床试验中的多样性、公平性和包容性：从试验赞助商的角度出发的实用指南。
Contemp Clin Trials. 2023 Mar;126:107092. doi: 10.1016/j.cct.2023.107092. Epub 2023 Jan 23.
8
Using psychological principles to narrow the intention-behavior gap and increase participation in HIV vaccine trials.运用心理学原理缩小意愿与行为之间的差距并提高对HIV疫苗试验的参与度。
Curr HIV Res. 2012 Sep;10(6):552-6. doi: 10.2174/157016212802429811.
9
Promoting equity, diversity, and inclusion in surveys: insights from a patient-engaged study to assess long COVID health-care needs in Brazil.促进调查中的公平、多样性和包容性：巴西一项患者参与研究评估长新冠保健需求的见解。
J Clin Epidemiol. 2024 Sep;173:111423. doi: 10.1016/j.jclinepi.2024.111423. Epub 2024 Jun 14.
10
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials.提高罕见病临床试验中的多样性、公平性、包容性和可及性。
Pharmaceut Med. 2024 Jul;38(4):261-276. doi: 10.1007/s40290-024-00529-8. Epub 2024 Jul 9.

引用本文的文献

1
Improving the reporting on health equity in observational research (STROBE-Equity): extension checklist and elaboration.改进观察性研究中健康公平性的报告（STROBE-公平性）：扩展清单及阐述
BMJ. 2025 Sep 3;390:e083882. doi: 10.1136/bmj-2024-083882.
2
Participation in clinical research among racial and ethnic minority Medicare beneficiaries: Evidence from the IDEAS study.医疗保险中种族和少数族裔受益人的临床研究参与情况：来自IDEAS研究的证据。
Alzheimers Dement. 2025 Jul;21(7):e70517. doi: 10.1002/alz.70517.
3
How Clinical Pharmacology Can Support Clinical Trial Diversity and Inclusion.
临床药理学如何支持临床试验的多样性与包容性。
Clin Transl Sci. 2025 Sep;18(9):e70332. doi: 10.1111/cts.70332.
4
Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry: A Randomized Clinical Trial.增加记忆问题登记处老年参与者多样性的经济激励措施：一项随机临床试验。
JAMA Health Forum. 2025 Aug 1;6(8):e252273. doi: 10.1001/jamahealthforum.2025.2273.
5
Racial and Ethnic Diversity in Clinical Studies Reported to ClinicalTrials.gov, 2009-2024.2009 - 2024年向ClinicalTrials.gov报告的临床研究中的种族和族裔多样性
medRxiv. 2025 Jul 21:2025.07.21.25331865. doi: 10.1101/2025.07.21.25331865.
6
Updated demographics categories to capture the true diversity of an international registry of rare disease patients.更新人口统计学类别，以反映罕见病患者国际登记处的真实多样性。
Ther Adv Rare Dis. 2025 Jul 31;6:26330040251359676. doi: 10.1177/26330040251359676. eCollection 2025 Jan-Dec.
7
Major Allele Frequencies in and in Asian and European Populations: A Case Study to Disaggregate Data Among Large Racial Categories.亚洲和欧洲人群中[具体内容]的主要等位基因频率：一项在大型种族类别中分解数据的案例研究。
J Pers Med. 2025 Jun 27;15(7):274. doi: 10.3390/jpm15070274.
8
The feasibility of the Community health worker Outreach and Navigation Network for Enhancing representation in Clinical Trials (CONNECT) model: A community-physician engagement approach for increasing representation in clinical trials.社区卫生工作者临床试验增强代表性外展与导航网络（CONNECT）模式的可行性：一种社区与医生合作以增加临床试验代表性的方法。
Contemp Clin Trials Commun. 2025 Jul 7;46:101521. doi: 10.1016/j.conctc.2025.101521. eCollection 2025 Aug.
9
Advancing equitable access to innovation in breast cancer.推进乳腺癌创新的公平可及性。
NPJ Breast Cancer. 2025 Jul 10;11(1):71. doi: 10.1038/s41523-025-00768-1.
10
Adherence to World Cancer Research Fund/American Institute for Cancer Research Guidelines and Mortality Among Participants with Colorectal Cancer in the MEC Cohort.遵循世界癌症研究基金会/美国癌症研究学会指南与MEC队列中结直肠癌参与者的死亡率
Cancer Epidemiol Biomarkers Prev. 2025 Jul 10. doi: 10.1158/1055-9965.EPI-25-0379.